Concurrent anti-glomerular basement membrane disease and membranous nephropathy: a case report [PDF]
Frontiers in MedicineAnti-glomerular basement membrane (GBM) disease is a rapidly progressive glomerulonephritis which, in rare instances, occurs concurrently with membranous nephropathy (MN).
Lin-Lin Li +4 more
doaj +2 more sources
Renal Failure, 2021 Introduction Anti-glomerular basement membrane (anti-GBM) disease is a small vessel vasculitis affecting the renal and lung capillary beds. We aim to study the clinicopathological characteristics and predictors of poor outcome of this disease in our ...
Zafirah Zahir +3 more
doaj +2 more sources
Anti-glomerular basement membrane disease-treatment standard. [PDF]
Nephrol Dial TransplantABSTRACT We review the current standards of treatment and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management of anti-glomerular basement membrane (anti-GBM) disease. Anti-GBM disease is a unique form of small vessel vasculitis affecting the glomerular and pulmonary capillaries. It is caused
McAdoo SP, Pusey CD.
europepmc +2 more sources
Diabetes mellitus with anti-glomerular basement membrane disease and anti-tubular basement membrane disease: a rare case report of reversible dialysis dependence [PDF]
Frontiers in ImmunologyWe present an instructive case of an elderly woman with a history of diabetes and diabetic retinopathy who was admitted due to rapidly progressive renal failure requiring dialysis.
Junqi Hu +3 more
doaj +2 more sources
The Prevalence and Characteristics of Circulating IgA Anti-Glomerular Basement Membrane Autoantibodies in Anti-Glomerular Basement Membrane Disease. [PDF]
Kidney Int Rep, 2023 In some cases, immunoglobulin (IgA)-mediated antiglomerular basement membrane (anti-GBM) disease has been reported. Whether circulating IgA anti-GBM antibodies affect the clinico-pathologic characteristics and outcome of typical anti-GBM disease deserves further study.Circulating IgA anti-α3(IV)NC1 antibodies were examined by enzyme-linked ...
Yang XF +7 more
europepmc +3 more sources
Anti–Glomerular Basement Membrane Disease after Alemtuzumab
New England Journal of Medicine, 2008 To the Editor: Alemtuzumab (Campath-1H) is a humanized anti-CD52 monoclonal antibody, the administration of which causes profound B- and T-lymphocyte depletion. It is licensed for use in the treatment of chronic lymphocytic leukemia, and it is increasingly used in the treatment of autoimmune diseases (particularly multiple sclerosis) and as an ...
Clatworthy, MR, Wallin, E, Jayne, DR
openaire +4 more sources
Atypical Anti–Glomerular Basement Membrane Disease [PDF]
Kidney International ReportsLoreto Fernández-Lorente +14 more
doaj +2 more sources
Atypical anti-glomerular basement membrane disease with membranous hyperplasia: diagnostic challenges and treatment variability [PDF]
BMC NephrologyThis case report presents a detailed analysis of a 31-year-old male patient who presented with a complex array of clinical symptoms, including proteinuria, hematuria, edema, and kidney insufficiency.
Ruoyu Tong +6 more
doaj +2 more sources
Estimating Prognosis in Anti-Glomerular Basement Membrane Disease. [PDF]
J Am Soc Nephrol, 2023 Glassock RJ.
europepmc +3 more sources